Stratipath

𝗛𝗮𝗽𝗽𝘆 𝗛𝗼𝗹𝗶𝗱𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝗦𝘁𝗿𝗮𝘁𝗶𝗽𝗮𝘁𝗵: 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝟱 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗮𝗻𝗱 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗮𝗵𝗲𝗮𝗱 𝘁𝗼 𝗮𝗻 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟱! As we close out our 5th year, we want to extend our deepest gratitude to everyone who has been part of this incredible journey. From the bottom of our hearts, thank you for your support, collaboration, and hard work in helping us deliver on our mission: “𝘛𝘩𝘦 𝘳𝘪𝘨𝘩𝘵 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘳𝘪𝘨𝘩𝘵 𝘱𝘢𝘵𝘪𝘦𝘯𝘵.”   2024 has been a year of significant milestones, and we could not be prouder of what we have achieved together. Here are some highlights:   𝗦𝘁𝗿𝗮𝘁𝗶𝗽𝗮𝘁𝗵 𝗕𝗿𝗲𝗮𝘀𝘁: Our pioneering solution has now been in clinical use for over a year in multiple hospitals, with even more joining the list. The interest from both within and beyond the Nordics is growing rapidly, and we are excited about the promising future! Learn more: https://lnkd.in/dhQNHeBa   𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻: This year, the scientific evidence behind Stratipath Breast has been strengthened significantly. Key validation studies have been published, including a landmark study with 2,700 patients that validated our AI-based solution’s performance. Another study successfully compared it to established gene expression tests. Read more: https://lnkd.in/dHMwutxb 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗺𝗲𝗻𝘁: Throughout 2024, we have rolled out several releases and updates to enhance Stratipath Breast, ensuring seamless integration into the breast cancer diagnostic workflow.   𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀: We have made great strides in integrating Stratipath into industry-leading platforms such as Proscia’s Concentriq Dx, Roche's Navify platform, Paige and continued our collaboration with Sectra.   𝗥𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 & 𝗮𝘄𝗮𝗿𝗱𝘀: 2024 has been a year of recognition, with Stratipath being awarded the Dream Award, the Health Tech Award, and named a Gold Company on Sweden’s 33-list of most innovative companies. We are honoured and proud.   𝗧𝗵𝗼𝘂𝗴𝗵𝘁 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: Our team has been on the move, presenting, lecturing, and hosting webinars and seminars on the role of AI in cancer care. We are excited to see this field growing in significance within the patient’s journey.   This is just a snapshot of all the achievements we have made, and none of it would have been possible without our amazing partners in healthcare, the industry, and of course, the hard-working team here at Stratipath.   A big thank you to everyone who has contributed to our success. Your dedication and passion are what drive us forward every day. We are incredibly excited about what 2025 has in store, and we look forward to continuing this important journey together.   Here’s to a bright future with more breakthroughs, innovations, and, most importantly, better patient outcomes! 🌟

The #DigiPathLondon conference in London has officially started! We’re thrilled to invite you to visit us at Booth 33 to discover Stratipath Breast, our cutting-edge AI solution for prognostic risk profiling in breast cancer. Let’s talk about: ✔️ How it works in the clinical setting ✔️ Its validation through large-scale independent studies ✔️ Seamless integration into diagnostic workflows ✔️ Delivering prognostic results on a patient’s risk of relapse - cost effective and fast ✔️ Can work as an alternative to gene expression tests We’re here to answer your questions and showcase how AI transforms breast cancer care. Welcome to Booth 33! Looking forward to meeting you, Annica & Stephanie

Busy conference week ahead for Stratipath! Next week, we’re excited to be part of two major events: December 11-12: The Digital Pathology & AI Conference in London by Global Engage Visit us at booth 33 to meet our Medical Manager, Stephanie Robertson, (MD, PhD and pathologist), or our COO, Annica Jämtén Ericsson. Feel free to stop by for a chat or book a meeting in advance! December 10-13: San Antonio Breast Cancer Symposium (SABCS). Representing Stratipath will be our CMO, Professor Johan Hartman, Emelie Karlsson, Customer support specialist, and our CEO, Fredrik Wetterhall. We’d love to connect—reach out to book a meeting or catch up with us on-site! #SABCS #DigiPathLondon #AI #DigitalPathology #BreastCancer #HealthcareInnovation #Stratipath

Tomorrow, Thursday the 5th, Stratipath CMO Johan Hartman will present ”AI in Breast Cancer Diagnostics: Possibilities and Challenges” at Bonnier Healthcare Sweden.

Today at ”Security Day” hosted by Certezza AB Stratipath CEO Fredrik Wetterhall will share insights on Stratipath’s journey from groundbreaking research to making a real difference for patients. Fredrik’s talk will also explore the key success factors for effectively implementing advanced AI solutions in healthcare. We’re looking forward to an inspiring event and meaningful discussions about the intersection of technology, innovation, and patient care! #AI #HealthcareInnovation #Stratipath #SecurityDay2024 https://sakerhetsdagen.se/

Another proud moment for Stratipath! Today, we were honored to receive the Gold Company award for being featured on Ny Teknik and Affärsvärlden’s prestigious list of Sweden’s 33 most innovative startups – for the third consecutive year! Our COO, Annica Jämtén Ericsson, had the privilege of accepting the award and delivering a pitch on how Stratipath’s innovations benefit cancer patients and transform cancer care. Meanwhile, our CEO, Fredrik Wetterhall, joined a dynamic on-stage discussion on growth alongside other industry leaders, including Claes Kollberg (Cemvision), Susanne Najafi (BackingMinds), Shamim Dadvar (HealthCap), Jan Erik Solem (Polar Rose & Mapillary), Leo Nilsson (Angel investor) and Maria Ljungberg (HSBC Innovation banking). We are deeply grateful for this recognition and inspired to continue driving innovation in AI-driven precision diagnostics! #Innovation #AI #CancerCare #Stratipath #33listan

Join us this Friday as Stratipath’s co-founder and CMO, Johan Hartman, delivers a lecture on “Implementation of AI-based Risk Stratification in Breast Pathology” at the symposium From Pathologists’ Eye to AI. Location: Swedish Society of Medicine, Klara Östra Kyrkogata 10, 101 35 Stockholm. Don’t miss the opportunity to connect with Stratipath representatives Annica Jämtén Ericsson and Lars Lengquist, who will be on-site for discussions and questions. This event is free to attend – register here: https://lnkd.in/dD4XqavD #AI #Pathology #HealthcareInnovation #BreastCancer

Stratipath’s CMO, Professor Johan Hartman, will join as a panelist at the seminar “Vi forskar för livet – för patienternas bästa” (We Research for Life – For the Benefit of Patients) at Folkhälsodalen this Wednesday, the 20th, at 10:50 AM. (arranged by Johnson & Johnson) The seminar will spotlight the crucial collaboration between patients, healthcare providers, academia, and industry to streamline the journey from clinical trials to implementing new treatments. Clinical trials form the bedrock of future healthcare – without them, no new therapies can emerge. Together, we can drive innovation and create meaningful change for patients worldwide. Date: Wednesday 20th November, kl 10.50 More info and registration: https://lnkd.in/dEwxrZGP?

Thrilled to share that Stratipath has been recognized as one of the Gold Companies on Ny Teknik and Affärsvärlden’s prestigious 33-list – for the maximum three consecutive years! Remaining on this list is a testament to our commitment to innovation in Swedish tech and the transformative potential of AI-driven precision diagnostics in cancer care. We’re honored to stand alongside the most forward-thinking companies in Sweden, and we extend heartfelt congratulations to all our fellow innovators on this journey. Together, we’re shaping the future of technology and healthcare. Congratulations: AirForestry, Amferia kills bacteria, ArgusEye, Atley Solutions, Avassa, Axellen, Blue Ocean Closures, Cellfion , CelluXtreme, Cemvision, Greeniron H2 AB, Embedl, Enerpoly, Eneryield, EpinovaTech AB, Flasheye , Flox, Helios Innovations 💧, Hypex Bio Explosives Technology, IPercept, LifeFinder, Ligna Energy, Nordic Forestry Automation, Novatron Fusion Group AB, RemotiveLabs, Reselo, PaperShell, SCALINQ, Sics AI, TERASi, VIDEM, Xertified #AI #PrecisionDiagnostics #Innovation #HealthcareTech #Stratipath https://lnkd.in/gtHmBK_7

Don’t miss out on a valuable opportunity to dive into the latest in breast cancer precision diagnostics. Bonnier Healthcare Sweden is hosting a focused session on breast cancer diagnostics, where Stratipath co-founder and professor, Johan Hartman, will be presenting “AI in Breast Cancer Diagnostics: Possibilities and Challenges.” This is a unique chance to learn about cutting-edge AI applications transforming breast cancer care. Date: 5th December. Seats are limited, so be sure to secure your spot! #BreastCancer #PrecisionDiagnostics #AI #Stratipath #CancerCare #HealthcareInnovation